Troubled times: With its back against the wall, little Tenax sends out an SOS while IMV takes out the budget axe, chops staff

The tally of restructurings in biotech continued to go up today with news from two small players that are in financial hot water.

Tenax Therapeutics may be down to its final crisis.

After years of spikes and plunges, the share price has long been flatlined in penny stock territory....

Click to view original post